BETA: Please send your feedback!
Eagle Pharmaceuticals
EGRX:NAS
Pharmaceuticals: Other
$0
SMALL cap
$48.51
(1.01%)
-0.20%
since start of 2020
47.05
About
Pharmaceuticals: Other
Founded 2007
Eagle Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the provision of injectable products. Its activities include development and commercialization of pharmaceutical products for the treatment of areas such as critical care, orphan diseases, and oncology. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Scott L. Tarriff, MBA | Chief Executive Officer & Director | Male |
| Peter E. Grebow, PhD | Executive Vice President-Research & Development | Male |
| David E. Riggs, MBA | Chief Financial Officer | Male |
| David M. Pernock | President & Chief Commercial Officer | Male |
| Adrian Hepner, MD, PhD | Executive Vice President & Chief Medical Officer | Male |
| Michael Graves | Chairman | Male |
| Steven L. Krill, PhD | Chief Scientific Officer & Executive VP | Male |
| John LaRocca | Chief Compliance Officer, EVP & General Counsel | Male |
Mindful Investing Summary
Eagle Pharmaceuticals - Competitors and Related Companies
How Eagle Pharmaceuticals stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Eagle Pharmaceuticals
EGRX:NAS
Pharmaceuticals: Other
$0
SMALL cap
$48.51
(1.01%)
-0.20%
since start of 2020
47.05
Madrigal Pharmaceuticals
MDGL:NAS
Pharmaceuticals: Other
$1.05bn
SMALL cap
$68.25
(2.06%)
-0.25%
since start of 2020
-12.52
Teva Pharmaceutical Industries
TEVA-IL:TAE
Pharmaceuticals: Generic
$11.18bn
LARGE cap
$10.23
(0.40%)
0.04%
since start of 2020
-11.18
Bristol-Myers Squibb
BMY:NYS
Pharmaceuticals: Major
$133.43bn
MEGA cap
$58.98
(0.72%)
-0.08%
since start of 2020
26.80
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
$96.76bn
MEGA cap
$38.85
(0.78%)
-0.17%
since start of 2020
16.28
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
$374.39bn
MEGA cap
$142.01
(-1.25%)
-0.03%
since start of 2020
24.86